Breast Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Breast Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 4 (2007), Issue 10 (October)

1. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
   J Clin Oncol, 25(28): 4423-30. [Abstract] [Full-text]
2. Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced breast cancer.
   J Clin Oncol, 25(28): 4405-13. [Abstract] [Full-text]
3. Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life.
   J Clin Oncol, 25(28): 4387-95. [Abstract] [Full-text]
4. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial.
   J Clin Oncol, 25(28): 4396-404. [Abstract] [Full-text]
5. Relationship between epidemiologic risk factors and breast cancer recurrence.
   J Clin Oncol, 25(28): 4438-44. [Abstract] [Full-text]
6. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
   J Clin Oncol, 25(28): 4414-22. [Abstract] [Full-text]
7. Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases.
   J Clin Oncol, 25(28): 4431-7. [Abstract] [Full-text]
8. Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.
   Radiat Res, 168(4): 415-22. [Abstract] [Full-text]
9. Care-seeking behaviors of African American women with breast cancer symptoms.
   Res Nurs Health, 30(5): 542-57. [Abstract] [Full-text]
10. Raft-dependent endocytosis of autocrine motility factor is phosphatidylinositol 3-kinase-dependent in breast carcinoma cells.
    J Biol Chem, 282(40): 29305-13. [Abstract] [Full-text]
11. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
    Int J Cancer, 121(10): 2307-16. [Abstract] [Full-text]
12. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Int J Cancer, 121(10): 2181-91. [Abstract] [Full-text]
13. Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen.
    J Mol Endocrinol, 39(4): 305-18. [Abstract] [Full-text]
14. Role of specificity protein transcription factors in estrogen-induced gene expression in MCF-7 breast cancer cells.
    J Mol Endocrinol, 39(4): 289-304. [Abstract] [Full-text]
15. C-reactive protein in nipple aspirate fluid associated with Gail model factors.
    Biol Res Nurs, 9(2): 108-16. [Abstract] [Full-text]
16. Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.
    Cancer Res, 67(19): 9584-90. [Abstract] [Full-text]
17. Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-kappaB pathway.
    Cancer Res, 67(19): 9577-83. [Abstract] [Full-text]
18. Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone.
    Cancer Res, 67(19): 9542-8. [Abstract] [Full-text]
19. A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes.
    Cancer Res, 67(19): 9528-34. [Abstract] [Full-text]
20. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78.
    Cancer Res, 67(19): 9507-17. [Abstract] [Full-text]
21. Association of Wwox with ErbB4 in breast cancer.
    Cancer Res, 67(19): 9330-6. [Abstract] [Full-text]
22. Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior.
    Cancer Res, 67(19): 9169-79. [Abstract] [Full-text]
23. Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells.
    Cancer Res, 67(19): 9117-24. [Abstract] [Full-text]
24. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression.
    Cancer Res, 67(19): 9066-76. [Abstract] [Full-text]
25. Fetal microchimerism in women with breast cancer.
    Cancer Res, 67(19): 9035-8. [Abstract] [Full-text]
26. Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1.
    Cancer Res, 67(19): 9030-4. [Abstract] [Full-text]
27. Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate.
    Cancer Res, 67(19): 9018-23. [Abstract] [Full-text]
28. Diagnosing and treating breast cancer in elderly women: a call for improved understanding.
    J Am Geriatr Soc, 55(10): 1636-44. [Abstract] [Full-text]
29. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.
    Int J Cancer, 121(11): 2532-8. [Abstract] [Full-text]
30. Biliverdin inhibits activation of NF-kappaB: reversal of inhibition by human biliverdin reductase.
    Int J Cancer, 121(11): 2567-74. [Abstract] [Full-text]
31. Influence of socioeconomic factors on survival after breast cancer--a nationwide cohort study of women diagnosed with breast cancer in Denmark 1983-1999.
    Int J Cancer, 121(11): 2524-31. [Abstract] [Full-text]
32. Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women.
    Int J Cancer, 121(11): 2517-23. [Abstract] [Full-text]
33. Hypoxia upregulates carcinoembryonic antigen expression in cancer cells.
    Int J Cancer, 121(11): 2443-50. [Abstract] [Full-text]
34. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
    Int J Cancer, 121(11): 2506-11. [Abstract] [Full-text]
35. AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells.
    J Cell Physiol, 213(3): 740-9. [Abstract] [Full-text]
36. The impact of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in human breast and bladder cancers.
    Cancer Chemother Pharmacol, 61(1): 23-32. [Abstract] [Full-text]
37. A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer.
    Cancer Chemother Pharmacol, 61(1): 125-31. [Abstract] [Full-text]
38. Increased Dickkopf-1 expression in breast cancer bone metastases.
    Br J Cancer, 97(7): 964-70. [Abstract] [Full-text]
39. Concomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: long-term follow-up.
    Br J Cancer, 97(7): 883-7. [Abstract] [Full-text]
40. Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse.
    Br J Cancer, 97(7): 957-63. [Abstract] [Full-text]
41. Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel.
    Br J Cancer, 97(7): 888-94. [Abstract] [Full-text]
42. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis.
    Nature, 449(7162): 557-63. [Abstract] [Full-text]
43. The theory of the sick breast lobe and the possible consequences.
    Int J Surg Pathol, 15(4): 369-75. [Abstract] [Full-text]
44. Anatomopathological analysis of sentinel and nonsentinel lymph nodes in breast cancer: hematoxylin-eosin versus immunohistochemistry.
    Int J Surg Pathol, 15(4): 358-68. [Abstract] [Full-text]
45. SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells.
    Biochem Biophys Res Commun, 363(2): 361-7. [Abstract] [Full-text]
46. Caspase-7 mediated cleavage of proteasome subunits during apoptosis.
    Biochem Biophys Res Commun, 363(2): 388-94. [Abstract] [Full-text]
47. Predicting the risk of local recurrence in patients with breast cancer: an approach to a new computer-based predictive tool.
    Am J Clin Oncol, 30(5): 473-80. [Abstract] [Full-text]
48. Local recurrence after mastectomy in patients with T3pN0 breast carcinoma treated without postoperative radiation therapy.
    Am J Clin Oncol, 30(5): 466-72. [Abstract] [Full-text]
49. National surgical patterns of care: regional lymphadenectomy of breast sarcomas.
    Am J Clin Oncol, 30(5): 461-5. [Abstract] [Full-text]
50. Early breast cancer therapy and cardiovascular injury.
    J Am Coll Cardiol, 50(15): 1435-41. [Abstract] [Full-text]
51. Mammographic density and dietary patterns: the multiethnic cohort.
    Eur J Cancer Prev, 16(5): 409-14. [Abstract] [Full-text]
52. Exploring the surgeon volume outcome relationship among women with breast cancer.
    Arch Intern Med, 167(18): 1958-63. [Abstract] [Full-text]
53. Fatigue after treatment for early stage breast cancer: a controlled comparison.
    Cancer, 110(8): 1851-9. [Abstract] [Full-text]
54. A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema.
    Cancer, 110(8): 1868-74. [Abstract] [Full-text]
55. Cyberknife radiosurgery for breast cancer spine metastases: a matched-pair analysis.
    Cancer, 110(8): 1796-802. [Abstract] [Full-text]
56. Breast cancer vaccines: promise for the future or pipe dream?
    Cancer, 110(8): 1677-86. [Abstract] [Full-text]
57. Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: analysis of data 3 to 6 years after treatment.
    Cancer, 110(8): 1840-50. [Abstract] [Full-text]
58. Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy.
    Cancer, 110(8): 1687-96. [Abstract] [Full-text]
59. BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.
    J Clin Oncol, 25(29): 4635-41. [Abstract] [Full-text]
60. Women's interest in gene expression analysis for breast cancer recurrence risk.
    J Clin Oncol, 25(29): 4628-34. [Abstract] [Full-text]
61. HER2 and response to paclitaxel in node-positive breast cancer.
    N Engl J Med, 357(15): 1496-506. [Abstract] [Full-text]
62. Enhanced surgery-induced angiogenesis among premenopausal women might partially explain excess breast cancer mortality of blacks compared to whites: an hypothesis.
    Int J Surg, 5(5): 300-4. [Abstract] [Full-text]
63. The boomerang incision for periareolar breast malignancies.
    Am J Surg, 194(5): 690-3. [Abstract] [Full-text]
64. Expression patterns of lymphangiogenic and angiogenic factors in a model of breast ductal carcinoma in situ.
    Am J Surg, 194(5): 594-9. [Abstract] [Full-text]
65. Network-based classification of breast cancer metastasis.
    Mol Syst Biol, 3: 140. [Abstract] [Full-text]
66. Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy.
    J Clin Oncol, 25(30): 4765-71. [Abstract] [Full-text]
67. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Expert Rev Anticancer Ther, 7(10): 1463-72. [Abstract] [Full-text]
68. Significance and management of micrometastases in patients with breast cancer.
    Expert Rev Anticancer Ther, 7(10): 1451-61. [Abstract] [Full-text]
69. National quality validation programs for breast centers.
    Expert Rev Anticancer Ther, 7(10): 1357-62. [Abstract] [Full-text]
70. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
    J Clin Oncol, 25(30): 4772-8. [Abstract] [Full-text]
71. Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells.
    J Control Release, 123(2): 164-71. [Abstract] [Full-text]
72. Familial breast/ovarian cancer and BRCA1/2 genetic screening: the role of immunohistochemistry as an additional method in the selection of patients.
    J Histochem Cytochem, 55(11): 1105-13. [Abstract] [Full-text]
73. Risk for leukaemia and brain and breast cancer among Danish utility workers: a second follow-up.
    Occup Environ Med, 64(11): 782-4. [Abstract] [Full-text]
74. Successful resection of giant solitary pulmonary metastasis from a phyllodes tumor.
    Ann Thorac Surg, 84(5): 1750-2. [Abstract] [Full-text]
75. Increased phosphorylation of Akt in triple-negative breast cancers.
    Cancer Sci, 98(12): 1889-92. [Abstract] [Full-text]
76. Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort.
    Am J Epidemiol, 166(10): 1150-8. [Abstract] [Full-text]
77. ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy.
    Int J Cardiol, 122(3): 195-201. [Abstract] [Full-text]
78. Isolation of CD24(high) and CD24(low/-) cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7.
    Cancer Lett, 258(1): 98-108. [Abstract] [Full-text]
79. Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.
    Biochem Pharmacol, 74(11): 1575-86. [Abstract] [Full-text]
80. Up-regulation of LOX-1 expression by TNF-alpha promotes trans-endothelial migration of MDA-MB-231 breast cancer cells.
    Cancer Lett, 258(1): 31-7. [Abstract] [Full-text]
81. On-line localization of the lumpectomy cavity using surgical clips.
    Int J Radiat Oncol Biol Phys, 69(4): 1305-9. [Abstract] [Full-text]
82. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
    Int J Radiat Oncol Biol Phys, 69(4): 1124-30. [Abstract] [Full-text]
83. Postmastectomy electron beam chest wall irradiation in women with breast cancer: a clinical step toward conformal electron therapy.
    Int J Radiat Oncol Biol Phys, 69(4): 1139-44. [Abstract] [Full-text]
84. Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume.
    Int J Radiat Oncol Biol Phys, 69(4): 1131-8. [Abstract] [Full-text]
85. Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts.
    Int J Cancer, 121(12): 2661-7. [Abstract] [Full-text]
86. ANXA7 expression represents hormone-relevant tumor suppression in different cancers.
    Int J Cancer, 121(12): 2628-36. [Abstract] [Full-text]
87. Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR-75.
    J Cell Physiol, 214(1): 110-6. [Abstract] [Full-text]

© 2004-2008 Breast Cancer Research Today. All Rights Reserved.